Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate

Farhan A. Alhusban, Peter C. Seville

Research output: Contribution to journalArticle

Abstract

The present study investigates the feasibility of using two types of carbomer (971 and 974) to prepare inhalable dry powders that exhibit modified drug release properties. Powders were prepared by spray-drying formulations containing salbutamol sulphate, 20-50% w/w carbomer as a drug release modifier and leucine as an aerosolization enhancer. Following physical characterization of the powders, the aerosolization and dissolution properties of the powders were investigated using a Multi-Stage Liquid Impinger and a modified USP II dissolution apparatus, respectively. All carbomer 974-modified powders and the 20% carbomer 971 powder demonstrated high dispersibility, with emitted doses of at least 80% and fine particle fractions of approximately 40%. The release data indicated that all carbomer-modified powders displayed a sustained release profile, with carbomer 971-modified powders obeying first order kinetics, whereas carbomer 974-modified powders obeyed the Higuchi root time kinetic model; increasing the amount of carbomer 971 in the formulation did not extend the duration of drug release, whereas this was observed for the carbomer 974-modified powders. These powders would be anticipated to deposit predominately in the lower regions of the lung following inhalation and then undergo delayed rather than instantaneous drug release, offering the potential to reduce dosing frequency and improve patient compliance.
Original languageEnglish
Pages (from-to)444-455
Number of pages12
JournalJournal of Microencapsulation
Volume26
Issue number5
DOIs
Publication statusPublished - Aug 2009

Fingerprint

Albuterol
Powders
Sulfates
sprayers
sulfates
delivery
Lung
drugs
Pharmaceutical Preparations
dissolving
Dissolution
carbomer
formulations
leucine
Spray drying
Kinetics
respiration
kinetics
Feasibility Studies
Patient Compliance

Keywords

  • spray-drying
  • salbutamol
  • leucine
  • carbomer
  • modified release
  • inhalation

Cite this

Alhusban, Farhan A. ; Seville, Peter C. / Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate. In: Journal of Microencapsulation. 2009 ; Vol. 26, No. 5. pp. 444-455.
@article{55889a13954940c6a690d953cdcfd022,
title = "Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate",
abstract = "The present study investigates the feasibility of using two types of carbomer (971 and 974) to prepare inhalable dry powders that exhibit modified drug release properties. Powders were prepared by spray-drying formulations containing salbutamol sulphate, 20-50{\%} w/w carbomer as a drug release modifier and leucine as an aerosolization enhancer. Following physical characterization of the powders, the aerosolization and dissolution properties of the powders were investigated using a Multi-Stage Liquid Impinger and a modified USP II dissolution apparatus, respectively. All carbomer 974-modified powders and the 20{\%} carbomer 971 powder demonstrated high dispersibility, with emitted doses of at least 80{\%} and fine particle fractions of approximately 40{\%}. The release data indicated that all carbomer-modified powders displayed a sustained release profile, with carbomer 971-modified powders obeying first order kinetics, whereas carbomer 974-modified powders obeyed the Higuchi root time kinetic model; increasing the amount of carbomer 971 in the formulation did not extend the duration of drug release, whereas this was observed for the carbomer 974-modified powders. These powders would be anticipated to deposit predominately in the lower regions of the lung following inhalation and then undergo delayed rather than instantaneous drug release, offering the potential to reduce dosing frequency and improve patient compliance.",
keywords = "spray-drying, salbutamol, leucine, carbomer, modified release, inhalation",
author = "Alhusban, {Farhan A.} and Seville, {Peter C.}",
year = "2009",
month = "8",
doi = "10.1080/02652040802456924",
language = "English",
volume = "26",
pages = "444--455",
journal = "Journal of Microencapsulation",
issn = "0265-2048",
publisher = "Informa Healthcare",
number = "5",

}

Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate. / Alhusban, Farhan A.; Seville, Peter C.

In: Journal of Microencapsulation, Vol. 26, No. 5, 08.2009, p. 444-455.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate

AU - Alhusban, Farhan A.

AU - Seville, Peter C.

PY - 2009/8

Y1 - 2009/8

N2 - The present study investigates the feasibility of using two types of carbomer (971 and 974) to prepare inhalable dry powders that exhibit modified drug release properties. Powders were prepared by spray-drying formulations containing salbutamol sulphate, 20-50% w/w carbomer as a drug release modifier and leucine as an aerosolization enhancer. Following physical characterization of the powders, the aerosolization and dissolution properties of the powders were investigated using a Multi-Stage Liquid Impinger and a modified USP II dissolution apparatus, respectively. All carbomer 974-modified powders and the 20% carbomer 971 powder demonstrated high dispersibility, with emitted doses of at least 80% and fine particle fractions of approximately 40%. The release data indicated that all carbomer-modified powders displayed a sustained release profile, with carbomer 971-modified powders obeying first order kinetics, whereas carbomer 974-modified powders obeyed the Higuchi root time kinetic model; increasing the amount of carbomer 971 in the formulation did not extend the duration of drug release, whereas this was observed for the carbomer 974-modified powders. These powders would be anticipated to deposit predominately in the lower regions of the lung following inhalation and then undergo delayed rather than instantaneous drug release, offering the potential to reduce dosing frequency and improve patient compliance.

AB - The present study investigates the feasibility of using two types of carbomer (971 and 974) to prepare inhalable dry powders that exhibit modified drug release properties. Powders were prepared by spray-drying formulations containing salbutamol sulphate, 20-50% w/w carbomer as a drug release modifier and leucine as an aerosolization enhancer. Following physical characterization of the powders, the aerosolization and dissolution properties of the powders were investigated using a Multi-Stage Liquid Impinger and a modified USP II dissolution apparatus, respectively. All carbomer 974-modified powders and the 20% carbomer 971 powder demonstrated high dispersibility, with emitted doses of at least 80% and fine particle fractions of approximately 40%. The release data indicated that all carbomer-modified powders displayed a sustained release profile, with carbomer 971-modified powders obeying first order kinetics, whereas carbomer 974-modified powders obeyed the Higuchi root time kinetic model; increasing the amount of carbomer 971 in the formulation did not extend the duration of drug release, whereas this was observed for the carbomer 974-modified powders. These powders would be anticipated to deposit predominately in the lower regions of the lung following inhalation and then undergo delayed rather than instantaneous drug release, offering the potential to reduce dosing frequency and improve patient compliance.

KW - spray-drying

KW - salbutamol

KW - leucine

KW - carbomer

KW - modified release

KW - inhalation

UR - http://www.scopus.com/inward/record.url?scp=70849132843&partnerID=8YFLogxK

UR - https://www.tandfonline.com/doi/full/10.1080/02652040802456924

U2 - 10.1080/02652040802456924

DO - 10.1080/02652040802456924

M3 - Article

VL - 26

SP - 444

EP - 455

JO - Journal of Microencapsulation

JF - Journal of Microencapsulation

SN - 0265-2048

IS - 5

ER -